Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

VYNE Therapeutics (VYNE) Change in Inventory (2019 - 2022)

VYNE Therapeutics (VYNE) has disclosed Change in Inventory for 4 consecutive years, with -$97000.0 as the latest value for Q1 2022.

  • For the quarter ending Q1 2022, Change in Inventory fell 114.1% year-over-year to -$97000.0, compared with a TTM value of -$97000.0 through Dec 2022, up 14.16%, and an annual FY2022 reading of -$97000.0, up 14.16% over the prior year.
  • Change in Inventory was -$97000.0 for Q1 2022 at VYNE Therapeutics, up from -$779000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $2.6 million in Q2 2020 and bottomed at -$779000.0 in Q4 2021.
  • Average Change in Inventory over 4 years is $719400.0, with a median of $721000.0 recorded in 2020.
  • The sharpest move saw Change in Inventory tumbled 44.4% in 2020, then plummeted 203.32% in 2021.
  • Year by year, Change in Inventory stood at $1.4 million in 2019, then crashed by 44.4% to $754000.0 in 2020, then tumbled by 203.32% to -$779000.0 in 2021, then soared by 87.55% to -$97000.0 in 2022.
  • Business Quant data shows Change in Inventory for VYNE at -$97000.0 in Q1 2022, -$779000.0 in Q4 2021, and -$209000.0 in Q3 2021.